Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy

G Sloan, D Selvarajah, S Tesfaye - Nature Reviews Endocrinology, 2021 - nature.com
Diabetic sensorimotor peripheral neuropathy (DSPN) is a serious complication of diabetes
mellitus and is associated with increased mortality, lower-limb amputations and distressing …

The impact of sensory neuropathy and inflammation on epithelial wound healing in diabetic corneas

XY Fu-Shin, PSY Lee, L Yang, N Gao, Y Zhang… - Progress in retinal and …, 2022 - Elsevier
Diabetic peripheral neuropathy (DPN) is the most common complication of diabetes, with
several underlying pathophysiological mechanisms, some of which are still uncertain. The …

Emerging biomarkers, tools, and treatments for diabetic polyneuropathy

GJ Bönhof, C Herder, A Strom, N Papanas… - Endocrine …, 2019 - academic.oup.com
Diabetic neuropathy, with its major clinical sequels, notably neuropathic pain, foot ulcers,
and autonomic dysfunction, is associated with substantial morbidity, increased risk of …

Advances in screening, early diagnosis and accurate staging of diabetic neuropathy

J Carmichael, H Fadavi, F Ishibashi… - Frontiers in …, 2021 - frontiersin.org
The incidence of both type 1 and type 2 diabetes is increasing worldwide. Diabetic
peripheral neuropathy (DPN) is among the most distressing and costly of all the chronic …

A systematic review and meta-analysis of the serum lipid profile in prediction of diabetic neuropathy

Z Cai, Y Yang, J Zhang - Scientific reports, 2021 - nature.com
Whether the lipid profile in diabetic patients is associated with diabetic neuropathy (DN)
development remains ambiguous, as does the predictive value of serum lipid levels in the …

Neuron-specific biomarkers predict hypo-and hyperalgesia in individuals with diabetic peripheral neuropathy

J Morgenstern, JB Groener, JME Jende, FT Kurz… - Diabetologia, 2021 - Springer
Aims/hypothesis The individual risk of progression of diabetic peripheral neuropathy is
difficult to predict for each individual. Mutations in proteins that are responsible for the …

Lipids and peripheral neuropathy

Z Iqbal, B Bashir, M Ferdousi, A Kalteniece… - Current Opinion in …, 2021 - journals.lww.com
Hyperlipidaemia, particularly hypertriglyceridemia, is associated with the development and
progression of neuropathy. Lipid modifying agents may represent a potential therapeutic …

Severe hypertriglyceridaemia and chylomicronaemia syndrome—causes, clinical presentation, and therapeutic options

B Bashir, JH Ho, P Downie, P Hamilton, G Ferns… - Metabolites, 2023 - mdpi.com
We have reviewed the genetic basis of chylomicronaemia, the difference between
monogenic and polygenic hypertriglyceridaemia, its effects on pancreatic, cardiovascular …

Association of serum cholesterol levels with peripheral nerve damage in patients with type 2 diabetes

JME Jende, JB Groener, C Rother, Z Kender… - JAMA network …, 2019 - jamanetwork.com
Importance Lowering serum cholesterol levels is a well-established treatment for
dyslipidemia in patients with type 2 diabetes (T2D). However, nerve lesions in patients with …

Diffusion tensor imaging of the sciatic nerve as a surrogate marker for nerve functionality of the upper and lower limb in patients with diabetes and prediabetes

JME Jende, Z Kender, C Mooshage… - Frontiers in …, 2021 - frontiersin.org
Background Nerve damage in diabetic neuropathy (DN) is assumed to begin in the distal
legs with a subsequent progression to hands and arms at later stages. In contrast, recent …